These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 848925)

  • 41. "In vitro" evaluation of Aspergillus susceptibility to antifungal agents.
    Viviani MA; Tortorano AM
    Ann Sclavo; 1982; 24(6):642-50. PubMed ID: 6320751
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of 5-fluorocytosine on the germination of Aspergillus fumigatus and on subsequent nuclear division.
    Wain WH; Polak A; Florio RA
    Sabouraudia; 1981 Jun; 19(2):147-53. PubMed ID: 7020112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp.
    Hughes CE; Harris C; Moody JA; Peterson LR; Gerding DN
    Antimicrob Agents Chemother; 1984 May; 25(5):560-2. PubMed ID: 6329088
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Multicenter study of the standardization of sensitivity testing of fungi to 5-fluorocytosine and amphotericin B].
    Polak A
    Mykosen; 1987 Jul; 30(7):306-8, 311-4. PubMed ID: 3657853
    [No Abstract]   [Full Text] [Related]  

  • 45. Combined activity of ketoconazole and 5-fluorocytosine on potentially pathogenic yeasts.
    Beggs WH; Sarosi GA
    Antimicrob Agents Chemother; 1982 Feb; 21(2):355-7. PubMed ID: 6280603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aspergillus--classification and antifungal susceptibilities.
    Buzina W
    Curr Pharm Des; 2013; 19(20):3615-28. PubMed ID: 23278534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathogenicity in mice of strains of Candida albicans with different in vitro sensitivity to 5-fluorocytosine.
    Persson M; Winblad B; Anséhn S; Schönebeck J
    Scand J Infect Dis; 1978; 10(1):87-90. PubMed ID: 345424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A study of 666 strains of Candida albicans: correlation between serotype and susceptibility to 5-fluorocytosine.
    Auger P; Dumas C; Joly J
    J Infect Dis; 1979 May; 139(5):590-4. PubMed ID: 374653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relative inhibition factors--a novel approach to the assessment of antifungal antibiotics in vitro.
    Odds FC; Abbott AB
    J Antimicrob Chemother; 1984 Jan; 13(1):31-43. PubMed ID: 6698909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variables influencing susceptibility testing of Cryptococcus neoformans to 5-fluorocytosine.
    Block ER; Jennings AE; Bennett JE
    Antimicrob Agents Chemother; 1973 Oct; 4(4):392-5. PubMed ID: 4598611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing.
    Utz CJ; Shadomy S
    J Infect Dis; 1977 Jun; 135(6):970-4. PubMed ID: 325150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods.
    Ernst EJ; Yodoi K; Roling EE; Klepser ME
    Antimicrob Agents Chemother; 2002 Feb; 46(2):578-81. PubMed ID: 11796383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine.
    Strippoli V; Torosantucci A; Simonetti N
    Chemioterapia; 1984 Apr; 3(2):119-25. PubMed ID: 6398120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proceedings: Synergism between 5-fluorocytosine and polyene antibiotics.
    Polak A
    Pathol Microbiol (Basel); 1975; 42(4):234-5. PubMed ID: 778764
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of antifungal combinations of nystatin-intralipid against Aspergillus terreus using checkerboard and disk diffusion methods.
    Semis R; Nahmias M; Lev S; Frenkel M; Segal E
    J Mycol Med; 2015 Mar; 25(1):63-70. PubMed ID: 25639922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on the purine-sensitive mutants of Bacillus subtilis. I. Properties of an adenosine-sensitive mutant.
    Kida M; Kawashima F; Imada A; Nogami I; Suhara I
    J Biochem; 1969 Oct; 66(4):487-92. PubMed ID: 4982128
    [No Abstract]   [Full Text] [Related]  

  • 57. In vitro interactions between amphotericin B, itraconazole, and flucytosine against 21 clinical Aspergillus isolates determined by two drug interaction models.
    Te Dorsthorst DT; Verweij PE; Meis JF; Punt NC; Mouton JW
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2007-13. PubMed ID: 15155192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Various cytosine/adenine permease homologues are involved in the toxicity of 5-fluorocytosine in Saccharomyces cerevisiae.
    Paluszynski JP; Klassen R; Rohe M; Meinhardt F
    Yeast; 2006 Jul; 23(9):707-15. PubMed ID: 16845689
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.
    Denning DW; Hanson LH; Perlman AM; Stevens DA
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):21-34. PubMed ID: 1309690
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [In vitro comparative study of the sensitivity of Aspergillus to antifungal agents].
    Guinet R; Mazoyer MA
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):654-7. PubMed ID: 6462761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.